<DOC>
	<DOCNO>NCT01815918</DOCNO>
	<brief_summary>One postoperative complication follow unilateral bilateral total knee replacement thrombosis ( blood clot formation ) . In prospective , double-blinded randomize controlled clinical trial , researcher investigate effect steroid biochemical marker thrombosis . Furthermore , elevate cellular marker thrombosis ( specifically IL-6 ) link postoperative depression follow total knee replacement surgery . Hence investigator also check use hydrocortisone , steroid , may help reduce incidence postoperative depression . Other study show surgery cause reaction body consistent inflammation . When inflammation extensive , may affect different part body . It may also lead clot disorder result blood clot . In previous study principal investigator ( see reference 22 , `` Use low-dose steroid decrease cytokine release bilateral total knee replacement '' ) , hydrocortisone administer 24 hour follow surgery patient underwent bilateral total knee replacement . The investigator find low level cellular marker consistent inflammation ( specifically protein , IL-6 ) . Steroid use also show additional benefit , decrease pain well range motion knee . In study , investigator recruit patient undergoing total knee replacement surgery . Patients randomize receive three 100 mg dos hydrocortisone three dos saline placebo . In addition analyze patient ' blood sample hydrocortisone 's effect clotting factor ( i.e . IL-6 ) , investigator record patient ' pain score patient ' oral analgesic use . To assess patient ' well-being , patient contact one month 3 month follow surgery administer Patient Health Questionnaire ( see reference 23 , `` The PHQ-9 : validity brief depression severity measure . '' )</brief_summary>
	<brief_title>The Effect Low Dose Corticosteroids Perioperative Markers Thrombosis Fibrinolysis Total Knee Replacement</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>All patient undergoing unilateral bilateral total knee replacement Age 5090 All patient steroid therapy regardless dose duration treatment require stressdose steroid preoperatively Patients smoker Patients 50 year age Patients 90 year age Patients diabetes Patients prior history corticosteroid intolerance Patients previous complication steroid use</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Orthopedic Procedures</keyword>
	<keyword>Prostheses Implants</keyword>
	<keyword>Joint Prosthesis</keyword>
	<keyword>Knee Prosthesis</keyword>
	<keyword>Arthroplasty , Replacement , Knee</keyword>
	<keyword>Thromboembolism</keyword>
	<keyword>Inflammation</keyword>
	<keyword>B-Cell Differentiation Factor-2</keyword>
	<keyword>Differentiation Factor-2 , B-Cell</keyword>
	<keyword>B-Cell Stimulatory Factor-2</keyword>
	<keyword>BSF-2</keyword>
	<keyword>IFN-beta 2</keyword>
	<keyword>MGI-2</keyword>
	<keyword>Interleukin-6 ( IL-6 )</keyword>
	<keyword>Steroids</keyword>
	<keyword>Pregnenediones</keyword>
	<keyword>Hydrocortisone</keyword>
	<keyword>Physiological Effects Drugs</keyword>
	<keyword>Therapeutic Uses</keyword>
</DOC>